Peripheral blood mononuclear cell secretome for tissue repair

Apoptosis

Volumn 21, Issue 12, 2016, Pages 1336-1353

  Beer, Lucian ^a   Mildner, Michael ^b   Gyöngyösi, Mariann ^a   Ankersmit, Hendrik Jan ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

Paracrine; PBMC; Regenerative medicine; Secretome; Tissue regeneration

Indexed keywords

LIPID; MICRORNA; PEPTIDES AND PROTEINS; SECRETOME; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; HUMAN; HYPOTHESIS; META ANALYSIS (TOPIC); MULTINUCLEAR CELL; NONHUMAN; PARACRINE SIGNALING; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATIVE MEDICINE; REVIEW; STEM CELL; TISSUE REPAIR; ANIMAL; CYTOLOGY; EXOSOME; GENETICS; METABOLISM; MONONUCLEAR CELL; WOUND HEALING;

ANIMALS; APOPTOSIS; EXOSOMES; HUMANS; LEUKOCYTES, MONONUCLEAR; REGENERATIVE MEDICINE; WOUND HEALING;

EID: 84989189532     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-016-1292-8     Document Type: Review

References (116)

1. Niehans P (1952) 20 Jahre Zellular-Therapie. Urban & Schwarzenberg, Berlin
2. Rietschel H (1954) Gefahren der Frischzellentherapie. Dtsch Med Wochenschr 79:1671–1673
3. Rietschel H (1955) Frischzellentherapie und ihre Gefharen. Wiener Med Wochenschr 46:949–957
4. Maximow AA (1909) Der lymphozyt als gemeinsame stammzelle der verschiedenen blutelement in der embryonalen entwicklung und im postfetalen leben der säugetiere. Folia Haematologica 8
5. Metchnikoff II (2004) The prolongation of life: optimistic studies. Springer, New York
6. Beltrami AP, Urbanek K, Kajstura J et al (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750–1757
7. Bergmann O, Bhardwaj RD, Bernard S et al (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98–102
8. Bergmann O, Zdunek S, Felker A et al (2015) Dynamics of cell generation and turnover in the human heart. Cell 161:1566–1575
9. Laflamme MA, Myerson D, Saffitz JE, Murry CE (2002) Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 90:634–640
10. Kocher AA, Schuster MD, Szabolcs MJ et al (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7:430–436
11. Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701–705
12. Assmus B, Schachinger V, Teupe C et al (2002) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009–3017
13. Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ (2014) Cell therapy for cardiac repair—lessons from clinical trials. Nat Rev Cardiol 11:232–246
14. Fisher SA, Doree C, Mathur A, Martin-Rendon E (2015) Meta-analysis of cell therapy trials for patients with heart failure. Circ Res 116:1361–1377
15. Fisher SA, Doree C, Taggart DP, Mathur A, Martin-Rendon E (2016) Cell therapy for heart disease: trial sequential analyses of two cochrane reviews. Clin Pharmacol Ther 100(1):88–101
16. Gyongyosi M, Wojakowski W, Lemarchand P et al (2015) Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res 116:1346–1360
17. Hatzistergos KE, Quevedo H, Oskouei BN et al (2010) Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 107:913–922
18. Premer C, Blum A, Bellio MA et al (2015) Allogeneic mesenchymal stem cells restore endothelial function in heart failure by stimulating endothelial progenitor cells. EBioMedicine 2:467–475
19. Hodgkinson CP, Bareja A, Gomez JA, Dzau VJ (2016) Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology. Circ Res 118:95–107
20. Losordo DW, Schatz RA, White CJ et al (2007) Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 115:3165–3172
21. Mansour S, Roy DC, Bouchard V et al (2010) COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design. J Cardiovasc Transl Res 3:153–159
22. Chen SL, Fang WW, Ye F et al (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92–95
23. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668–673
24. Murry CE, Soonpaa MH, Reinecke H et al (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664–668
25. Nguyen PK, Lan F, Wang Y, Wu JC (2011) Imaging: guiding the clinical translation of cardiac stem cell therapy. Circ Res 109:962–979
26. Kwak BR, Mach F (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11:367
27. Mirotsou M, Zhang Z, Deb A et al (2007) Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci 104:1643–1648
28. Gnecchi M, Melo LG (2009) Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol Biol 482:281–294
29. Gnecchi M, Zhang Z, Ni A, Dzau VJ (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204–1219
30. Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC (2016) Paracrine mechanisms of mesenchymal stem cells in tissue repair. Methods Mol Biol 1416:123–146
31. Wollert KC, Drexler H (2005) Mesenchymal stem cells for myocardial infarction promises and pitfalls. Circulation 112:151–153
32. Korf-Klingebiel M, Kempf T, Sauer T et al (2008) Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 29:2851–2858
33. Thum T, Bauersachs J, Poole-Wilson PA, Volk HD, Anker SD (2005) The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 46:1799–1802
34. Wollert KC, Meyer GP, Lotz J et al (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141–148
35. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101:890–898
36. Ankersmit HJ, Hoetzenecker K, Dietl W et al (2009) Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest 39:445–456
37. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257
38. Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N (2013) Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta 1833:3448–3459
39. Stark MA, Huo Y, Burcin TL, Morris MA, Olson TS, Ley K (2005) Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22:285–294
40. Erwig LP, Henson PM (2007) Immunological consequences of apoptotic cell phagocytosis. Am J Pathol 171:2–8
41. Palmer E (2003) Negative selection—clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol 3:383–391
42. de la Rosa EJ, de Pablo F (2000) Cell death in early neural development: beyond the neurotrophic theory. Trends Neurosci 23:454–458
43. Vollrath D, Yasumura D, Benchorin G et al (2015) Tyro3 modulates Mertk-associated retinal degeneration. PLoS Genet 11:e1005723
44. Ankersmit HJ, Tugulea S, Spanier T et al (1999) Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 354:550–555
45. Ankersmit H, Moser B, Teufel I et al (2001) Increased death inducing receptors in vivo and activation-induced T-cell death by anti-thymocyte antibody treatment of stable cardiac transplant recipients. J Heart Lung Transplant 20:187
46. Ankersmit HJ, Deicher R, Moser B et al (2001) Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis. Clin Exp Immunol 125:142–148
47. Moser B, Roth G, Brunner M et al (2003) Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun 308:581–585
48. Roth GA, Krenn C, Brunner M et al (2004) Elevated serum levels of epithelial cell apoptosis-specific cytokeratin 18 neoepitope m30 in critically ill patients. Shock 22:218–220
49. Brunner M, Krenn C, Roth G et al (2004) Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med 30:1468–1473
50. Roth G, Moser B, Krenn C et al (2003) Susceptibility to programmed cell death in T-lymphocytes from septic patients: a mechanism for lymphopenia and Th2 predominance. Biochem Biophys Res Commun 308:840–846
51. Szondy Z, Garabuczi E, Joos G, Tsay GJ, Sarang Z (2014) Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications. Front Immunol 5:354
52. Saas P, Daguindau E, Perruche S (2016) Concise review: apoptotic cell-based therapies-rationale, preclinical results and future clinical developments. Stem Cells 34(6):1464–1473
53. Perruche S, Saas P, Chen W (2009) Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy? Arthritis Res Ther 11:R104
54. Ren Y, Xie Y, Jiang G et al (2008) Apoptotic cells protect mice against lipopolysaccharide-induced shock. J Immunol 180:4978–4985
55. Gray M, Miles K, Salter D, Gray D, Savill J (2007) Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA 104:14080–14085
56. Notley CA, Brown MA, Wright GP, Ehrenstein MR. (2011) Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J Immunol 186:4967–4972
57. Zhang M, Xu S, Han Y, Cao X (2011) Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β. Hepatology 53:306–316
58. Sirois I, Raymond MA, Brassard N et al (2011) Caspase-3-dependent export of TCTP: a novel pathway for antiapoptotic intercellular communication. Cell Death Differ 18:549–562
59. Huang Q, Li F, Liu X et al (2011) Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med 17:860–866
60. Beer L, Zimmermann M, Mitterbauer A et al (2015) Analysis of the secretome of apoptotic peripheral blood mononuclear cells: impact of released proteins and exosomes for tissue regeneration. Sci Rep 5:16662
61. Xia C-Q, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ (2007) Transfusion of apoptotic β-cells induces immune tolerance to β-cell antigens and prevents type 1 diabetes in NOD mice. Diabetes 56:2116–2123
62. Xia C-Q, Qiu Y, Peng R-H, Lo-Dauer J, Clare-Salzler MJ (2008) Infusion of UVB-treated splenic stromal cells induces suppression of β cell antigen-specific T cell responses in NOD mice. J Autoimmun 30:283–292
63. Miyake Y, Asano K, Kaise H, Uemura M, Nakayama M, Tanaka M (2007) Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell–associated antigens. J Clin Invest 117:2268–2278
64. Qiu C-H, Miyake Y, Kaise H, Kitamura H, Ohara O, Tanaka M (2009) Novel subset of CD8α+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens. J Immunol 182:4127–4136
65. Gray M, Miles K, Salter D, Gray D, Savill J (2007) Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci 104:14080–14085
66. Notley CA, Brown MA, McGovern JL, Jordan CK, Ehrenstein MR (2015) Engulfment of activated apoptotic cells abolishes TGF-β–mediated immunoregulation via the induction of IL-6. J Immunol 194:1621–1627
67. Grau A, Tabib A, Grau I, Reiner I, Mevorach D (2015) Apoptotic cells induce NF-κB and inflammasome negative signaling. PLoS One 10:e0122440
68. Yoon Y, Kim S, Kim M, Lim J, Cho M, Kang J (2015) PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines. Mucosal Immunol 8:1031–1046
69. Lee Y-J, Moon C, Lee SH et al (2012) Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction. Eur Respir J 40:424–435
70. Yoon Y-S, Lee Y-J, Choi J-Y, Cho M-S, Kang JL (2013) Coordinated induction of cyclooxygenase-2/prostaglandin E2 and hepatocyte growth factor by apoptotic cells prevents lung fibrosis. J Leukoc Biol 94:1037–1049
71. Huynh M-LN, Fadok VA, Henson PM (2002) Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation. J Clin Invest 109:41–50
72. Hotchkiss RS, Chang KC, Grayson MH et al (2003) Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci 100:6724–6729
73. Kushwah R, Oliver JR, Zhang J, Siminovitch KA, Hu J (2009) Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells. J Immunol 183:7104–7118
74. Zhang M, Xu S, Han Y, Cao X (2011) Apoptotic cells attenuate fulminant hepatitis by priming Kupffer cells to produce interleukin-10 through membrane-bound TGF-β. Hepatology 53:306–316
75. Griffith TS, Kazama H, VanOosten RL et al (2007) Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL. J Immunol 178:2679–2687
76. Ferguson TA, Herndon J, Elzey B, Griffith TS, Schoenberger S, Green DR (2002) Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8+ T cells produce active immune unresponsiveness. J Immunol 168:5589–5595
77. Sun E, Gao Y, Chen J et al (2004) Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient. Cell Death Differ 11:1258–1264
78. Wang Z, Larregina A, Shufesky W et al (2006) Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant 6:1297–1311
79. Kleist C, Sandra-Petrescu F, Jiga L et al (2015) Generation of suppressive blood cells for control of allograft rejection. Clin Sci 128:593–607
80. Wang Z, Shufesky WJ, Montecalvo A, Divito SJ, Larregina AT, Morelli AE (2009) In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS One 4:e4940
81. Mougel F, Bonnefoy F, Kury-Paulin S et al (2012) Intravenous infusion of donor apoptotic leukocytes before transplantation delays allogeneic islet graft rejection through regulatory T cells. Diabetes Metab 38:531–537
82. Wu C, Zhang Y, Jiang Y et al (2013) Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells. Cell Mol Immunol 10:393–402
83. de Carvalho Bittencourt M, Perruche S, Contassot E et al (2001) Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 98:224–230
84. Perruche S, Kleinclauss F, Bittencourt Mde C, Paris D, Tiberghien P, Saas P (2004) Intravenous infusion of apoptotic cells simultaneously with allogeneic hematopoietic grafts alters anti-donor humoral immune responses. Am J Transplant 4:1361–1365
85. Kleinclauss F, Perruche S, Masson E et al (2006) Intravenous apoptotic spleen cell infusion induces a TGF-β-dependent regulatory T-cell expansion. Cell Death Differ 13:41–52
86. Bonnefoy F, Masson E, Perruche S et al (2008) Sirolimus enhances the effect of apoptotic cell infusion on hematopoietic engraftment and tolerance induction. Leukemia 22:1430
87. Bonnefoy F, Perruche S, Couturier M et al (2011) Plasmacytoid dendritic cells play a major role in apoptotic leukocyte-induced immune modulation. J Immunol 186:5696–5705
88. Lichtenauer M, Mildner M, Werba G et al (2012) Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction. PLoS One 7:e52101
89. Földes I, Varkonyi S, Solti F, Kocze A (1970) Effect of antilymphocyte serum on experimental myocardial infarction. Experientia 26:741–743
90. Notley CA, Brown MA, McGovern JL, Jordan CK, Ehrenstein MR. (2015) Engulfment of activated apoptotic cells abolishes TGF-beta-mediated immunoregulation via the induction of IL-6. J Immunol 194:1621–1627
91. Wang Z, Larregina AT, Shufesky WJ et al (2006) Use of the inhibitory effect of apoptotic cells on dendritic cells for graft survival via T-cell deletion and regulatory T cells. Am J Transplant 6:1297–1311
92. Bonnefoy F, Masson E, Perruche S et al (2008) Sirolimus enhances the effect of apoptotic cell infusion on hematopoietic engraftment and tolerance induction. Leukemia 22:1430–1434
93. Perotti C, Arici V, Cervio M et al (2013) Allogeneic lethally irradiated cord blood mononuclear cells in no-option critical limb ischemia: a “box of rain”. Stem Cells Dev 22:2806–2812
94. Holzinger C, Zuckermann A, Kopp C et al (1994) Treatment of non-healing skin ulcers with autologous activated mononuclear cells. Eur J Vasc Surg 8:351–356
95. Ankersmit H, Moser B, Zuckermann A et al (2002) Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients. Clin Exp Immunol 128:175–180
96. Ankersmit H, Ullrich R, Moser B et al (2006) Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report. Thorac Cardiovasc Surg 54:278–280
97. Lichtenauer M, Mildner M, Hoetzenecker K et al (2011) Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic Res Cardiol 106:1283–1297
98. Lichtenauer M, Mildner M, Baumgartner A et al (2011) Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol 106:645–655
99. Hoetzenecker K, Assinger A, Lichtenauer M et al (2012) Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation. Basic Res Cardiol 107:292
100. Hoetzenecker K, Zimmermann M, Hoetzenecker W et al (2015) Mononuclear cell secretome protects from experimental autoimmune myocarditis. Eur Heart J 36:676–685
101. Mildner M, Hacker S, Haider T et al (2013) Secretome of peripheral blood mononuclear cells enhances wound healing. PLoS One 8:e60103
102. Pavo N, Zimmermann M, Pils D et al (2014) Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction. Biomaterials 35:3541–3550
103. Altmann P, Mildner M, Haider T et al (2014) Secretomes of apoptotic mononuclear cells ameliorate neurological damage in rats with focal ischemia. F1000Res 3:131
104. Haider T, Hoftberger R, Ruger B et al (2015) The secretome of apoptotic human peripheral blood mononuclear cells attenuates secondary damage following spinal cord injury in rats. Exp Neurol 267:230–242
105. Hacker S, Mittermayr R, Nickl S et al (2016) Paracrine factors from irradiated peripheral blood mononuclear cells improve skin Regeneration and angiogenesis in a porcine burn model. Sci Rep 6:25168
106. David S, Zarruk JG, Ghasemlou N (2012) Inflammatory pathways in spinal cord injury. Int Rev Neurobiol 106:127–152
107. Kasiri MM, Beer L, Nemec L et al (2016) Dying blood mononuclear cell secretome exerts antimicrobial activity. Eur J Clin Invest. doi:10.1111/eci.12667
108. Beer L, Seemann R, Ristl R et al (2014) High dose ionizing radiation regulates micro RNA and gene expression changes in human peripheral blood mononuclear cells. BMC Genom 15:814
109. Boland K, Flanagan L, Prehn JH. (2013) Paracrine control of tissue regeneration and cell proliferation by Caspase-3. Cell Death Dis 4:e725
110. Lauber K, Bohn E, Krober SM et al (2003) Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113:717–730
111. Gallina C, Turinetto V, Giachino C (2015) A new paradigm in cardiac regeneration: the mesenchymal stem cell secretome. Stem Cells Int 2015:765846
112. Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373–383
113. Okoye IS, Coomes SM, Pelly VS et al (2014) MicroRNA-containing T-regulatory-cell-derived exosomes suppress pathogenic T helper 1 cells. Immunity 41:89–103
114. Costa-Silva B, Aiello NM, Ocean AJ et al (2015) Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 17:816–826
115. Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E (2015) Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev 24:1635–1647
116. Gabriel C (2014) How to establish and run a cell therapy unit in a blood bank. ISBT Sci Ser 9:155–159